NRx Pharmaceuticals (NRXP)
Develops NMDA-pathway CNS therapies alongside a majority-owned interventional-psychiatry clinic network.
$3.44
Pre-market−0.02 (−0.54%)
At close$3.46(+0.44%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions38 holders · as of Mar 31, 2026 | 35.90% | 6.20M shares | |
| Insiders1 holder · as of Dec 18, 2024 | 0.49% | 84.6K shares | |
| Strategic holders1 holder · as of May 26, 2021 | 0.38% | 65.6K shares | |
| Otherremainder | 63.23% | 10.93M shares |
17.29M company shares as of Aug 21, 2026 · institutions as of Mar 31, 2026 · holders as of their latest filing
Two share counts disagree (43.30M in the company's Sep 3, 2026 report, 17.29M elsewhere); stakes use the report.
Institutions13F, as of Mar 31, 2026
38 holders · 6.20M shares · 10 new positions · 23 increased · 3 reduced · 6 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| B Group, Inc. | 3.00M | 17.36% | +3.00Mnew | May 15, 2026 |
| Vanguard Capital Management LLC | 1.16M | 6.71% | +1.16Mnew | May 15, 2026 |
| Advisorshares Investments LLC | 420.5K | 2.43% | +92.5K | Apr 28, 2026 |
| Commonwealth Equity Services, LLC | 397.4K | 2.30% | +30.8K | Apr 27, 2026 |
| Geode Capital Management, LLC | 310.1K | 1.79% | +91.2K | May 15, 2026 |
| Vanguard Fiduciary Trust Co | 169.6K | 0.98% | +169.6Knew | May 8, 2026 |
| Bleakley Financial Group, LLC | 117.2K | 0.68% | 0 | May 4, 2026 |
| BlackRock, Inc. | 99.0K | 0.57% | +16.3K | May 13, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| The B Group, Inc. | 12.62% | 3.00M | 13G | Aug 21, 2025 ↗ |
| Anson Funds Management LP | 9.30% | 1.60M | 13G | Aug 14, 2025 ↗ |
Insider tradesForm 4
Latest trades
No open-market trades in the last 12 months.
CongressHouse and Senate disclosures
Not reported.
